Thomas Wilson
Investor Relations Kontakt bei THOE HEAL
Profil
Thomas Wilson is currently the Vice President & Head-Investor Relations at Thorne HealthTech, Inc. since 2022.
Prior to this, he worked as the Head-Investor Relations at PPD, Inc.
Aktive Positionen von Thomas Wilson
Unternehmen | Position | Beginn |
---|---|---|
THOE HEAL | Investor Relations Kontakt | 01.01.2022 |
Ehemalige bekannte Positionen von Thomas Wilson
Unternehmen | Position | Ende |
---|---|---|
PPD, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
PPD, Inc.
PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Thorne HealthTech, Inc.
Thorne HealthTech, Inc. Packaged SoftwareTechnology Services Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. It utilizes testing and data to create improved product quality and deliver personalized solutions to consumers, health professionals, and professional sports teams. It also helps pharmaceutical and biotechnology companies repurpose existing drugs and compounds, improve existing medications and develop new products. The company was founded by Paul Jacobson in 2010 and is headquartered in New York, NY. | Technology Services |